Lava Medtech Acquisition Stock Cash Flow From Operations
| LVACUDelisted Stock | USD 10.40 0.00 0.00% |
Lava Medtech Acquisition fundamentals help investors to digest information that contributes to Lava Medtech's financial success or failures. It also enables traders to predict the movement of Lava Stock. The fundamental analysis module provides a way to measure Lava Medtech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lava Medtech stock.
Lava |
Lava Medtech Acquisition Company Cash Flow From Operations Analysis
Lava Medtech's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Lava Medtech Cash Flow From Operations | (658.82 K) |
Most of Lava Medtech's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lava Medtech Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, Lava Medtech Acquisition has (658,824) in Cash Flow From Operations. This is 100.03% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The cash flow from operations for all United States stocks is 100.07% higher than that of the company.
Lava Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lava Medtech's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lava Medtech could also be used in its relative valuation, which is a method of valuing Lava Medtech by comparing valuation metrics of similar companies.Lava Medtech is currently under evaluation in cash flow from operations category among its peers.
Lava Fundamentals
| Return On Asset | -0.0081 | |||
| Shares Owned By Institutions | 10.18 % | |||
| Number Of Shares Shorted | 105 | |||
| EBITDA | (6.22 M) | |||
| Net Income | 4.5 M | |||
| Cash And Equivalents | 1.15 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 92.81 K | |||
| Debt To Equity | 4.92 % | |||
| Current Ratio | 18.29 X | |||
| Book Value Per Share | (0.21) X | |||
| Cash Flow From Operations | (658.82 K) | |||
| Short Ratio | 1.88 X | |||
| Total Asset | 120.67 M | |||
| Retained Earnings | (3.01 M) | |||
| Working Capital | (3.39 M) | |||
| Z Score | -0.24 | |||
| Net Asset | 120.67 M |
About Lava Medtech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lava Medtech Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lava Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lava Medtech Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Lava Stock
If you are still planning to invest in Lava Medtech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lava Medtech's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |